Botulax for sale

Firstly, botulax for sale. A white injectable dry powder in a transparent glass vial which should become a colorless, transparent liquid when reconstituted with a solvent (normal saline solution)

Description

Botulax 100iu – Composition
Each vial contains:

Active ingredient: Clostridium botulinum toxins type A (100 units).
Stabilizer: Human serum albumin 0.5mg
Tonic Adjuster: Sodium chloride (KP) 0.9mg

Buy Botulax 200iu

Description:
Also, it appears a a lyophilized white powder for injection in a colorless transparent vial

Mode of action

Furthermore, botulinum Toxin Type A blocks signals from the nerves to the muscles.
The injected muscle can no longer contract, which causes the wrinkles to relax and soften.
It is most often used on forehead lines, crow’s feet (lines around the eye) and frown lines.
Features and Benefits

Botulax For Sale UK

More-so, botulax guarantees high patient satisfaction.
Potency variation is strictly controlled to within 91-115 units/ vial, more stringent than the legally required range.
Size of toxin complex is 900kDa, minimize spread of botulinum toxin outside of the injection site.
Such large and homogeneous size of the toxin complex ensures precise and uniform effect at the time of injection, guaranteeing high patient satisfaction with Botulax
Botulax is providing more choices.
Botulax is launch in the market as a 100unit product. Development of 25, 50,and 200-unit products are underway, “one vial for one patient”injection will be realized soon to minimized the risk of secondary infection.

Buy Botulax Online

However, what is Botulax? Botulax contains 100 units (U) of Clostridium botulinum toxin type A, 0.5 milligrams of albumin (human)and 0.9 milligrams of sodium chloride in a sterile, vacuum-dried from without a preservative. Botulinum toxin type A neutroxin: purified from Clostridium botulinum type A Albumin: Human serum albumin,bulking and stabilizing agent and adhesion reducer. KP grade NaCl: Bulking agent and keeping isotonicity during formulation KP grade Developmental status: 2007.5: reported nonclinical study 2008.3: reported clinically study Phase l 2009.7: Finished Phase lll clinically study Characteristics of Botulax:Higher specific activity than those of other company’s botolinum toxin products by improving lyophilization process Facility: GMP approved by KFDA